BPC-157 tackles this problem directly by: Stimulating neoangiogenesis within the tendon or ligament substance Activating tenocytes (tendon cells) to produce organized collagen Reducing fibrotic adhesion formation that limits range of motion Condition-by-Condition Clinical Applications Tendinopathies Chronic tendon conditionsAchilles, patellar, rotator cuff, lateral epicondyle (tennis elbow), medial epicondyle (golfers elbow)respond exceptionally well to BPC-157
In briefing documents and presentations during the FDAs Pharmacy Compounding Advisory Committee meeting, agency scientific staff firmly opposed allowing compounding of the peptides under consideration BPC-157, KPV, TB-500, MOTS-c, emideltide, epitalon, and semax citing a lack of safety and efficacy evidence
Some semaglutide formulations also have both B6 and B12 to help relieve side effects, such as nausea, or prevent lethargy and fatigue in patients taking GLP-1 drugs for weight loss or type 2 diabetes
Range of motion expands